Efficacy of a Streamlined Heart Failure Optimization Protocol
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Prospective, Observational Study in Sickle Cell Disease Patients on Crizanlizumab Treatment in Middle East Countries and India
- Status
- TERMINATED
- Phase
- N/A
DreaMS - Validation Study 1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Pharmacokinetics Study of FIA586 in Participants With Mild and Moderate Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)
- Status
- TERMINATED
- Phase
- PHASE2
Regulatory Post-Marketing Surveillance Study for Brolucizumab
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy
- Status
- TERMINATED
- Phase
- PHASE3
Study Assessing Long-term Safety and Efficacy of Alpelisib in Patients With PIK3CA-Related Overgrowth Spectrum (PROS) Who Previously Participated in Study CBYL719F12002 (EPIK-P1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting
- Status
- TERMINATED
- Phase
- N/A
Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma.
- Status
- COMPLETED
- Phase
- N/A
Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC
- Status
- TERMINATED
- Phase
- PHASE2
Asciminib Treatment Optimization in ≥ 3rd Line CML-CP
- Status
- COMPLETED
- Phase
- PHASE3
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
- Status
- TERMINATED
- Phase
- PHASE2
A Post Marketing Surveillance on Lutathera® in Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine Tumor in Korea
- Status
- COMPLETED
- Phase
- N/A
A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia
- Status
- COMPLETED
- Phase
- N/A
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
- Status
- COMPLETED
- Phase
- N/A
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Russian Registry of Patients With nAMD
- Status
- TERMINATED
- Phase
- N/A